Dopamine in autism spectrum disorders—focus on D2/D3 partial agonists and their possible use in treatment

V Mandic-Maravic, R Grujicic, L Milutinovic… - Frontiers in …, 2022 - frontiersin.org
Autism spectrum disorders (ASD) are a group of disorders characterized by impairment in
social communication and repetitive and stereotyped behaviors. ASD etiology is very …

Neuronal dopamine D3 receptors: translational implications for preclinical research and CNS disorders

B Kiss, I Laszlovszky, B Krámos, A Visegrády, A Bobok… - Biomolecules, 2021 - mdpi.com
Dopamine (DA), as one of the major neurotransmitters in the central nervous system (CNS)
and periphery, exerts its actions through five types of receptors which belong to two major …

Unveiling the multitarget anti-Alzheimer drug discovery landscape: A bibliometric analysis

A Sampietro, FJ Pérez-Areales, P Martínez, EM Arce… - Pharmaceuticals, 2022 - mdpi.com
Multitarget anti-Alzheimer agents are the focus of very intensive research. Through a
comprehensive bibliometric analysis of the publications in the period 1990–2020, we have …

Manual acupuncture benignly regulates blood-brain barrier disruption and reduces lipopolysaccharide loading and systemic inflammation, possibly by adjusting the …

Y Zhang, N Ding, X Hao, J Zhao, Y Zhao… - Frontiers in Aging …, 2022 - frontiersin.org
Background Blood-brain barrier (BBB) disruption and gut microbiota dysbiosis play crucial
roles in Alzheimer's disease (AD). Lipopolysaccharide (LPS) stimulation triggered by gut …

[HTML][HTML] Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer's disease

K Kucwaj-Brysz, H Baltrukevich, K Czarnota… - Bioorganic & Medicinal …, 2021 - Elsevier
Despite the better understanding of the mechanisms underlying Alzheimer's Disease (AD)
and launched clinical trials, no AD-modifying treatment based on a synthetic drug has been …

Dopaminergic signaling as a plausible modulator of astrocytic toll-like receptor 4: a crosstalk between neuroinflammation and cognition

PC Gurram, S Manandhar, S Satarker… - CNS & Neurological …, 2023 - ingentaconnect.com
Neuroinflammation is one of the major pathological factors leading to Alzheimer's disease
(AD). The role of microglial cells in neuroinflammation associated with AD has been known …

The Phenoxyalkyltriazine Antagonists for 5-HT6 Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic …

S Sudoł, A Cios, M Jastrzębska-Więsek… - International Journal of …, 2021 - mdpi.com
Among the serotonin receptors, one of the most recently discovered 5-HT6 subtype is an
important protein target and its ligands may play a key role in the innovative treatment of …

An exit beyond the pharmacophore model for 5-HT6R agents-a new strategy to gain dual 5-HT6/5-HT2A action for triazine derivatives with procognitive potential

K Kucwaj-Brysz, W Ali, R Kurczab, S Sudoł-Tałaj… - Bioorganic …, 2022 - Elsevier
This research allowed us to find the first highly potent 5-HT 6/5-HT 2A receptor (5-HT 6/5-HT
2A R) dual antagonists in a group of 1, 3, 5-triazine compounds as a result of an exit beyond …

5-HT interaction with other neurotransmitters: an overview

P De Deurwaerdere, G Di Giovanni - Progress in Brain Research, 2021 - Elsevier
Abstract Serotonin (5-HT) biological functions are complex and multifaceted. It controls
almost all central nervous system (CNS) regions from cell bodies confined in the brainstem …

Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics

C Bombardi, A Grandis, N Pivac, M Sagud… - Progress in brain …, 2021 - Elsevier
The hippocampal region receives a dense serotoninergic innervation originating from both
medial and dorsal raphe nuclei. This innervation regulates hippocampal activity through the …